Matthew Pollard

City:

Dural

Country:

Australia

Published Applications:

Last publication date:

2024-05-02

Top Assignees for applications by Matthew Pollard

The entities that hold a legal rights for patent applications filed by inventor Pollard Matthew:

Teva Pharmaceuticals Australia Pty Ltd 5 Macquarie Park, Australia
Cephalon LLC 1 West Chester, PA United States
CEPHALON AUSTRALIA PTY LTD. 1 Macquarie Park, Australia
Teva Pharmaceuticals Australia Pty Ltd 1 Macquarie Park, NSW, Australia

Recent patent applications by Pollard Matthew

Matthew Pollard from Dural, AU has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-02

US20240141053A1

Chemistry; metallurgy

ANTIBODIES AGAINST TL1A AND USES THEREOF

#2 | 2021-11-11

US20210347904A1

Chemistry; metallurgy

ANTIBODIES AGAINST TL1A AND USES THEREOF

#3 | 2017-08-17

US20170233449A1

Chemistry; metallurgy

Fusions of antibodies to CD38 and attenuated interferon alpha

#4 | 2016-12-22

US20160367695A1

Human necessities

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

#5 | 2016-11-17

US20160333104A1

Chemistry; metallurgy

Antibodies against TL1a and uses thereof

#6 | 2014-09-25

US20140286957A1

Chemistry; metallurgy

ANTIBODIES TO CD1d

#7 | 2014-09-11

US20140255302A1

Chemistry; metallurgy

ANTIBODIES AGAINST TL1a AND USES THEREOF

#8 | 2014-09-04

US20140248238A1

Chemistry; metallurgy

Fusions of antibodies to CD38 and attenuated interferon alpha

#9 | 2010-11-25

US20100297134A1

Chemistry; metallurgy

Humanised antibodies with anti-tumour activity

InventorID:

895435 ⎘